KYTX (KYTX) Stock Price & Analysis
KYTX (KYTX) fell 1.20% to USD 8.25 as of September 8, 2026 at 05:02 UTC, according to Nexqual real-time market data.
KYTX last closed at USD 8.25; the session ranged USD 8.2–8.38 on volume of 500,823 shares. Market capitalization is —, with a 52-week range of USD 3.74–13.67 (NMS). Source: Nexqual, September 8, 2026 at 05:02 UTC.
Key Statistics (as of September 8, 2026 at 05:02 UTC)
| Price | USD 8.25 |
|---|---|
| Change | ▼ 1.20% (down) |
| Previous Close | USD 8.25 |
| Open | USD 8.25 |
| Day Range | USD 8.2 – 8.38 |
| 52-Week Range | USD 3.74 – 13.67 |
| Volume | 500,823 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (KYTX)
Nexqual's technical model rates KYTX "NEUTRAL" based on 2 bullish and 3 bearish signals across 128 daily candles, as of September 8, 2026 at 05:02 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 50.65 (neutral) |
| vs SMA50 | Above (USD 8.19) |
| MACD | 0.11 (positive) |
From KYTX's Latest SEC 10-K Filing (filed 2026-03-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ANRO | Alto Neuroscience, Inc. | USD 35.55 | ▼ 2.97% |
| CGON | CG Oncology, Inc. | USD 74.67 | ▲ 0.11% |
| CABA | Cabaletta Bio, Inc. | USD 3.47 | ▼ 2.8% |
| ARTV | Artiva Biotherapeutics, Inc. | USD 11.19 | ▼ 1.06% |
| ALMS | Alumis Inc. | USD 11.1 | ▲ 7.25% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:02 UTC. This page is informational and not investment advice.